Vnitr Lek 2023, 69(7):E21-E28 | DOI: 10.36290/vnl.2023.095

Malnutrition in chronic liver disease

Marie Ryšánková, Marek Šatný
IV. interní klinika - gastroenterologie a hepatologie, Všeobecná fakultní nemocnice v Praze, 1. lékařská fakulta UK

Malnutrition is common in advanced chronic liver disease (ACLD) negatively affecting both patient morbidity and mortality. Etiopathogenesis is multifactorial and includes insufficient food intake, malabsorption, metabolism alteration towards catabolism and increased energy expenditure. The diagnostic process involves conscientious history taking, basic biometric measurements, functional muscle tests, and with increasing significance also core muscle mass assessment using CT scan. Therapy consists of sufficient nutrients, minerals and micronutrients intake which can be achieved by increased oral intake or using enteral or parenteral nutrition. The aim of this article is to summarize the current knowledge regarding pathogenesis, diagnostics and therapy methods of malnutrition in the specific population of patients with chronic liver disease.

Keywords: malnutrition, liver cirrhosis, biometry, sarcopenia, GLIM criteria, nutritional intervention.

Accepted: October 26, 2023; Published: October 26, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ryšánková M, Šatný M. Malnutrition in chronic liver disease. Vnitr Lek. 2023;69(7):E21-28. doi: 10.36290/vnl.2023.095.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Sharma A, Nagalli S, Chronic Liver Disease. 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554597
    2. Aller de la Fuente R. Nutrition and Chronic Liver Disease. Clin Drug Investig. 2022; 42(Suppl):55-61. Go to original source... Go to PubMed...
    3. Traub J, Reiss L, Aliwa B, et al. Malnutrition in Patients with Liver Cirrhosis. Nutrients. 2021:13(2). Go to original source... Go to PubMed...
    4. Huisman EJ, Trip EJ, Siersema PD, et al. Protein energy malnutrition predicts complications in liver cirrhosis. Eur J Gastroenterol Hepatol. 2011;23(11):982-9. Go to original source... Go to PubMed...
    5. Maharshi S, Sharma BC, Srivastava S. Malnutrition in cirrhosis increases morbidity and mortality. J Gastroenterol Hepatol. 2015;30(10):1507-13. Go to original source... Go to PubMed...
    6. Peng S, Plank LD, McCall JL, et al. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study. Am J Clin Nutr. 2007,85(5):1257-66. Go to original source... Go to PubMed...
    7. Dirchwolf M, Ruf AE. Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis. World J Hepatol. 2015,7(16):1974-81. Go to original source... Go to PubMed...
    8. Campillo B. Richardet JP. Scherman E, et al., Evaluation of nutritional practice in hospitalized cirrhotic patients: results of a prospective study. Nutrition. 2003;19(6):51521. Go to original source... Go to PubMed...
    9. Chapman B, Sinclair M, Gow P. J, et al. Malnutrition in cirrhosis: More food for thought. World J Hepatol. 2020;12(11):883-896. Go to original source... Go to PubMed...
    10. Fritz E. Hammer J. Gastrointestinal symptoms in patients with liver cirrhosis are linked to impaired quality of life and psychological distress. Eur J Gastroenterol Hepatol. 2009;21(4):370-5. Go to original source... Go to PubMed...
    11. Kalaitzakis E, Bosaeus I, Ohman L, et al. Altered postprandial glucose, insulin, leptin, and ghrelin in liver cirrhosis: correlations with energy intake and resting energy expenditure. Am J Clin Nutr. 2007;85(3):808-15. Go to original source... Go to PubMed...
    12. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem. 2004;50(9):1511-25. Go to original source... Go to PubMed...
    13. Kalaitzakis E. Gastrointestinal dysfunction in liver cirrhosis. World J Gastroenterol. 2014;20(40):14686-95. Go to original source... Go to PubMed...
    14. Plauth M, Bernal W, Dasarathy S, et al. ESPEN guideline on clinical nutrition in liver disease. Clin Nutr. 2019;38(2):485-521. Go to original source... Go to PubMed...
    15. Chang K.V, Chen JD, Wu WT, et al. Is sarcopenia associated with hepatic encephalopathy in liver cirrhosis? A systematic review and meta­‑analysis. J Formos Med. Assoc 2019;118(4):833-842. Go to original source... Go to PubMed...
    16. Merli M, Giusto M, Lucidi C, et al., Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study. Metab Brain, DiS. 2013;28(2):281-4. Go to original source... Go to PubMed...
    17. Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol. 2016;65(6):1232-1244. Go to original source... Go to PubMed...
    18. Schneeweiss B, Pammer J, Ratheiser K, et al. Energy metabolism in acute hepatic failure. Gastroenterology. 1993;105(5):1515-21. Go to original source... Go to PubMed...
    19. Levine JA, Harris MM,; Morgan MY. Energy expenditure in chronic alcohol abuse. Eur J Clin Invest. 2000;30(9):779-86. Go to original source... Go to PubMed...
    20. Cederholm T, Jensen GL, Correia M, et al. GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community. Clin Nutr. 2019;38(1):1-9. Go to original source... Go to PubMed...
    21. Boulhosa R, Lourenço RP, Côrtes DM, et al. Comparison between criteria for diagnosing malnutrition in patients with advanced chronic liver disease: GLIM group proposal versus different nutritional screening tools. J Hum Nutr Diet. 2020;3(6):862-868. Go to original source... Go to PubMed...
    22. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019;70(1):172-193.
    23. Carey EJ, Lai, JC, Wang CW, et al. A multicenter study to define sarcopenia in patients with end­‑stage liver disease. Liver Transpl. 2017;23(5):625-633. Go to original source... Go to PubMed...
    24. van Vugt JL, Levolger S, de Bruin RW, et al. Systematic Review and Meta­‑Analysis of the Impact of Computed Tomography­‑Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation. Am J Transplan.t 2016;16(8):2277-92. Go to original source... Go to PubMed...
    25. Kara M, Kaymak B, Frontera W, et al. Diagnosing sarcopenia: Functional perspectives and a new algorithm from the ISarcoPRM. J Rehabil Med. 2021;53(6), jrm00209. Go to original source... Go to PubMed...
    26. Iwasa M, Iwata K, Hara N, et al. Nutrition therapy using a multidisciplinary team improves survival rates in patients with liver cirrhosis. Nutrition. 2013;29(11-12):1418-21. Go to original source... Go to PubMed...
    27. Chen HW, Ferrando A, White MG, et al. Home­‑Based Physical Activity and Diet Intervention to Improve Physical Function in Advanced Liver Disease: A Randomized Pilot Trial. Dig Dis Sci. 2020;65(11):3350-3359. Go to original source... Go to PubMed...
    28. Córdoba J, López­‑Hellín J, Planas M, et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol. 2004;41(1):38-43. Go to original source... Go to PubMed...
    29. Bischoff SC, Bernal W, Dasarathy S, et al. ESPEN practical guideline: Clinical nutrition in liver disease. Clin Nutr. 2020;39(12):3533-3562. Go to original source... Go to PubMed...
    30. Aller R, De Luis DA, Izaola O, et al. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. Eur Rev Med Pharmacol Sci. 2011;15(9):1090-5.
    31. Musazadeh V, Roshanravan N, Dehghan P, et al. Effect of Probiotics on Liver Enzymes in Patients With Non­‑alcoholic Fatty Liver Disease: An Umbrella of Systematic Review and Meta­‑Analysis. Front Nutr. 2022;9:844242. Go to original source... Go to PubMed...
    32. Als­‑Nielsen B, Koretz RL, Kjaergard LL, et al. Branched­‑chain amino acids for hepatic encephalopathy. Cochrane Database Syst Rev. 2003;(2):Cd001939. Go to original source...
    33. Baki J, Brown P, Tapper EB. Do Nutritional Interventions Improve the Outcomes of Patients with Cirrhosis and Ascites: A Systematic Review of Randomized Trials. Curr Hepatol Rep. 2020;19(2):71-77. Go to original source... Go to PubMed...
    34. Venu M, Martin E, Saeian K, et al. High prevalence of vitamin A deficiency and vitamin D deficiency in patients evaluated for liver transplantation. Liver Transpl. 2013; 19(6),627-33. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.